导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 53.10% | 34/1050 |
| 近一周 | -0.99% | 119/1104 |
| 近一月 | -3.25% | 379/1102 |
| 近一季 | -11.93% | 758/1092 |
| 近半年 | 48.89% | 18/1070 |
| 近一年 | 66.24% | 33/1018 |
| 近两年 | 242.13% | 35/926 |
| 近三年 | 163.88% | 47/834 |
| 成立以来 | 274.57% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-1.12% 564/1070 |
105.51% 28/1101 |
- - |
- - |
| 2025 | 86.45% 27/1065 |
-2.11% 916/1014 |
5.39% 277/1038 |
72.30% 9/1050 |
4.89% 141/1065 |
| 2024 | -2.82% 652/1011 |
-6.58% 639/960 |
-0.04% 310/983 |
4.07% 907/991 |
0.01% 318/1011 |
| 2023 | -14.19% 489/952 |
11.64% 89/880 |
10.35% 19/895 |
-25.20% 886/915 |
-6.89% 663/952 |
| 2022 | -30.03% 634/867 |
-25.77% 723/773 |
8.94% 301/806 |
-0.44% 18/845 |
-13.10% 825/867 |
| 2021 | 51.28% 14/740 |
-6.93% 415/580 |
37.23% 26/659 |
10.41% 57/704 |
7.28% 138/740 |
| 2020 | 61.41% 187/554 |
7.32% 53/419 |
36.28% 54/466 |
-0.72% 429/517 |
11.16% 330/554 |
| 2019 | 37.10% 241/410 |
15.39% 1003/1146 |
-6.20% 789/1228 |
14.33% 46/390 |
10.80% 142/410 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 海富通电子传媒股票C VS. 东吴新产业精选股票A(580008) |